GoodRx Holdings (GDRX) Other Accumulated Expenses (2019 - 2023)

GoodRx Holdings has reported Other Accumulated Expenses for 5 years, with the latest figure at $8.5 million in Q1 2023.

• Quarterly Other Accumulated Expenses rose 77.36% year-over-year to $8.5 million in Q1 2023, while the trailing twelve-month figure through Mar 2023 was $8.5 million (up 77.36% YoY) and the FY2022 annual result came in at $6.9 million, up 58.98% from the prior year.
• Other Accumulated Expenses grew to $8.5 million in Q1 2023 per GDRX's latest filing, from $6.9 million in the prior quarter.
• Over five years, Other Accumulated Expenses peaked at $11.4 million in Q3 2022 and troughed at $1.9 million in Q4 2019.
• A 5-year average of $5.9 million and a median of $5.2 million in 2021 frame the typical range for Other Accumulated Expenses.
• The sharpest annual moves came in 2020 and 2021: Other Accumulated Expenses surged 278.91% in 2020, then plunged 39.64% in 2021.
• Over 5 years, Other Accumulated Expenses stood at $1.9 million in 2019, then soared by 278.91% to $7.2 million in 2020, then slumped by 39.64% to $4.3 million in 2021, then jumped by 58.98% to $6.9 million in 2022, then gained by 23.44% to $8.5 million in 2023.
• According to Business Quant data, Other Accumulated Expenses over the past three periods registered $8.5 million, $6.9 million, and $11.4 million for Q1 2023, Q4 2022, and Q3 2022 respectively.